Novartis Venture Fund
Isabelle Lanthier has extensive experience in the pharmaceutical industry, currently serving as the Therapeutic Area Head for Oncology & Hematology in the LACAN region at Novartis since June 2021, alongside responsibilities as Global Indication Lead for Immuno-Oncology. Prior to this role, Isabelle held various leadership positions at Sandoz and Bristol-Myers Squibb, including Business Unit Lead for the Biosimilar and Specialty Franchise and Worldwide Commercial Director for ImmunoScience, where significant contributions were made to the commercialization of key oncology products. Isabelle's career also includes positions at Merck, Schering-Plough Pharmaceuticals, Pfizer Canada, and other notable companies, showcasing a strong background in marketing and strategic management across multiple therapeutic areas. Isabelle holds a Doctoral Studies degree in Political Science from Université du Québec à Montréal, complemented by executive education at Wharton.
This person is not in any teams
This person is not in any offices